Trademark: 77509976
Status Date
Friday, June 17, 2016
Registration Number
3707494
Registration Date
Tuesday, November 10, 2009
Filing Date
Friday, June 27, 2008
Published for Opposition
Tuesday, May 19, 2009
Cancellation Date
Friday, June 17, 2016
5 Blood products for humans, namely, pharmaceutical preparations for the treatment of blood or bleeding disorders and deficiencies of blood coagulation; fibrinogen concentrate for use in the treatment of blood or bleeding disorders and deficiencies of blood coagulation; blood clotting agents and antihemophilic factors for use in the treatment of hemophilia or von Willebrand disease; and blood proteins for therapeutic use
Jun 17, 2016
Cancelled Sec. 8 (6-Yr)
Sep 21, 2011
Teas Change Of Correspondence Received
Nov 10, 2009
Registered-Principal Register
Oct 1, 2009
1(B) Basis Deleted; Proceed To Registration
Sep 25, 2009
Notice Of Allowance Cancelled
Oct 1, 2009
Case Assigned To Intent To Use Paralegal
Sep 25, 2009
Teas Delete 1(B) Basis Received
Aug 11, 2009
Noa Mailed - Sou Required From Applicant
May 19, 2009
Published For Opposition
Apr 29, 2009
Notice Of Publication
Apr 15, 2009
Law Office Publication Review Completed
Apr 14, 2009
Approved For Pub - Principal Register
Apr 14, 2009
Examiner's Amendment Entered
Apr 14, 2009
Notification Of Examiners Amendment E-Mailed
Apr 14, 2009
Examiners Amendment E-Mailed
Apr 14, 2009
Examiners Amendment -Written
Mar 25, 2009
Notification Of Final Refusal Emailed
Mar 25, 2009
Final Refusal E-Mailed
Mar 25, 2009
Final Refusal Written
Mar 24, 2009
Amendment From Applicant Entered
Mar 24, 2009
Correspondence Received In Law Office
Mar 24, 2009
Assigned To Lie
Mar 23, 2009
Paper Received
Sep 30, 2008
Notification Of Non-Final Action E-Mailed
Sep 30, 2008
Non-Final Action E-Mailed
Sep 30, 2008
Non-Final Action Written
Sep 30, 2008
Assigned To Examiner
Jul 3, 2008
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
